The Effects of Rotator Interval Hydro-dissection in Primary Adhesive Capsulitis.

University of Malaya60 enrolled

Overview

Adhesive capsulitis (AC) is a significant cause of chronic shoulder pain and disability. Non-surgical option consisting of intraarticular corticosteroid (IA CS) injection with structured physiotherapy (PT) is the current standard of care. More recent randomized controlled trials have found that rotator interval (RI) hydro-dissection approach leads to better improvement in pain as compared to IA approach. Despite being non-inferior to surgical management, long-term outcome studies of patients treated with IA CS injection and PT have shown that patients only achieve satisfactory outcomes in 72.3% of patients after a mean symptom duration of 41.8 months. Furthermore, CS injections are associated with significant systemic and local adverse effects such as Cushing syndrome, osteopenia/ osteoporosis, infection, and hyperglycemia. In recent years, dextrose injection has emerged as an effective alternative to CS-based injections to treat chronic painful musculoskeletal conditions such as chronic low back pain, peripheral nerve entrapment and lateral epicondylitis. The investigators aim to study the effects of RI hydro-dissection with dextrose 5% (D5%) on pain relief, shoulder ROM and shoulder function in patients with primary AC.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Adhesive Capsulitis of Shoulder

Rotator interval hydro-dissection with dextrose 5%DRUG

Single injection of 20ml dextrose 5% into the rotator interval around the long head biceps tendon under ultrasound guidance using a 11-14 Hz frequency linear probe

Rotator interval hydro-dissection with corticosteroid solutionDRUG

Single injection of 20ml corticosteroid solution (1 ml triamcinolone 40 mg/ml + 19 ml saline 0.9%) into the rotator interval around the long head biceps tendon under ultrasound guidance using a 11-14 Hz frequency linear probe

Eligibility

Sex: ALLMin age: 35 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * patients with primary adhesive capsulitis * aged 35 to 65 years of age * duration of symptoms in between 3 to 18 months * limitation in flexion, abduction, and external rotation greater than 30 degrees compared to normal * limitation in internal rotation with hand to back shoulder test below L4 Exclusion Criteria: * diagnosis of connective tissue disease or inflammatory arthritis * history of surgery to the affected shoulder * history of shoulder dislocation/ fracture * neurological weakness of the affected upper limb * ultrasound findings of rotator cuff or LHBT tendinopathy * plain radiographs showing significant glenohumeral joint osteoarthritis (Kallgren-Lawrence grade 3 or 4) * other sources of chronic pain * bilateral adhesive capsulitis * history of pain intervention to the shoulder joint in the past 3 months * allergic reaction to local anesthetic agent

Outcomes

Primary Outcomes

Shoulder pain

Shoulder pain based on Shoulder Pain and Disability Index (SPADI) pain scale. The SPADI pain scale ranges from 0 to 50, with higher score indicating greater level of pain.

Time frame: 1 week, 4 weeks and 12 weeks post injection

Secondary Outcomes

Shoulder range of motion

Shoulder range of motion in flexion, abduction, external rotation, internal rotation

Time frame: 4 weeks and 12 weeks post injection

Shoulder function

Shoulder function based on Shoulder Pain and Disability Index (SPADI) disability scale. The SPADI disability scale ranges from 0 to 80, with higher score indicating greater level of disability.